Delving into the Latest Updates on Sudershan Biotech Ltd with Synapse

Overview

Tags

Hemic and Lymphatic Diseases

Colony-stimulating factors

Biosimilar

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	2

Top 5 Drug Type	Count

Biosimilar	2
Colony-stimulating factors	2

Top 5 Target	Count

EPO receptor(Erythropoietin receptor)	1
CSF-3R(Colony stimulating factor 3 receptor)	1

The erythropoietin was expressed in Chinese Hamster Ovary (CHO) cells and culture techniques were developed, purification process was developed.Different culture conditions were tried to evaluate the influence of various factors on erythropoietin production expressed in Chinese Hamster Ovary Cells.The productivity was checked at different harvests and found that the EPO expression was stable upto 10 harvest, sialidase activity was checked, effect of addition of sodium butyrate was studied on the productivity of erythropoietin (EPO).

100 Deals associated with Sudershan Biotech Ltd

Login to view more data

100 Translational Medicine associated with Sudershan Biotech Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Erythropoietin biosimilar(Sudershan Biotech Ltd) ( EPO receptor )	Anemia More	Approved
Filgrastim biosimilar(Sudershan Biotech Ltd) ( CSF-3R )	Neutropenia More	Approved